This website uses cookies to enhance the user experience.
||
N

NEONATAL ANALYTICS AS931 763 954

Limited company
Gaustadalléen 21 0349 OSLO, Norge

NEONATAL ANALYTICS AS

Under liquidation: 08/25/2025, Voluntary liquidation
Forskning, utvikling, salg, leveranse og drift av screeningsystemer for sykdommer.

Organization

Chairman of the board
Years since formation
2 years
since Aug 24, 2023
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
30,000
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Annual total result 2024
35
NOK
Total equity 2024
30,039
NOK
Last update: Sep 17, 2025

Management

Board

NameRoleShares
Chairman-
Last update: Aug 24, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
I
INVEN2 AS
Ordinary shares
30,000
100 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2024: NOK 83,852,000
    Operating profit 2024: NOK -26,817,000
    Employees: 32

Financials

in NOK

Summary

Year20242023
Total operating income
0
4
Annual Total Result
35
4
Total assets
30,039
30,000
Total liabilities
0
0
Total equity
30,039
30,000

P&L

Year20242023
Total operating income
0
4
Total operating costs
0
0
Operating result
0
4
Financial income/costs
35
0
Profit before tax
35
4
Total tax & extraordinary income/cost
0
0
Annual Total Result
35
4

Balance overview

Year20242023
Total fixed assets
0
0
Total current assets
30,039
30,000
Total assets
30,039
30,000
Short term debt
0
0
Long term debt
0
0
Total liabilities
0
0
Contributed capital
30,000
30,000
Retained earnings
39
0
Total equity
30,039
30,000
Total equity and liabilities
30,039
30,000

Classification

21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
1120
Public incorporated enterprises, owned by central government